Rank | Gene Set | Z-score |
---|---|---|
1 | chaperone-mediated protein transport (GO:0072321) | 4.93176184 |
2 | proteasome assembly (GO:0043248) | 4.91733260 |
3 | negative regulation of dendrite morphogenesis (GO:0050774) | 4.76514495 |
4 | DNA deamination (GO:0045006) | 4.74413825 |
5 | negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051436) | 4.70245343 |
6 | neuron cell-cell adhesion (GO:0007158) | 4.64349815 |
7 | regulation of cellular amino acid metabolic process (GO:0006521) | 4.54330285 |
8 | synaptic vesicle exocytosis (GO:0016079) | 4.49580038 |
9 | establishment of protein localization to mitochondrial membrane (GO:0090151) | 4.43008716 |
10 | vocalization behavior (GO:0071625) | 4.36898275 |
11 | DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest (GO:00 | 4.35557478 |
12 | negative regulation of ubiquitin-protein transferase activity (GO:0051444) | 4.33728040 |
13 | negative regulation of ligase activity (GO:0051352) | 4.33728040 |
14 | termination of RNA polymerase III transcription (GO:0006386) | 4.30389356 |
15 | transcription elongation from RNA polymerase III promoter (GO:0006385) | 4.30389356 |
16 | positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051437) | 4.26959335 |
17 | presynaptic membrane assembly (GO:0097105) | 4.23574240 |
18 | signal transduction involved in mitotic cell cycle checkpoint (GO:0072413) | 4.20727218 |
19 | signal transduction involved in mitotic DNA integrity checkpoint (GO:1902403) | 4.20727218 |
20 | signal transduction involved in mitotic DNA damage checkpoint (GO:1902402) | 4.20727218 |
21 | signal transduction involved in mitotic G1 DNA damage checkpoint (GO:0072431) | 4.20609943 |
22 | intracellular signal transduction involved in G1 DNA damage checkpoint (GO:1902400) | 4.20609943 |
23 | neuronal action potential propagation (GO:0019227) | 4.18116999 |
24 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 4.17297065 |
25 | regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051439) | 4.15848794 |
26 | respiratory chain complex IV assembly (GO:0008535) | 4.10891332 |
27 | regulation of N-methyl-D-aspartate selective glutamate receptor activity (GO:2000310) | 4.08901714 |
28 | signal transduction involved in DNA integrity checkpoint (GO:0072401) | 4.05753377 |
29 | signal transduction involved in DNA damage checkpoint (GO:0072422) | 4.05753377 |
30 | protein localization to synapse (GO:0035418) | 4.03718608 |
31 | signal transduction involved in cell cycle checkpoint (GO:0072395) | 4.01075432 |
32 | cytochrome complex assembly (GO:0017004) | 3.97147321 |
33 | regulation of mitochondrial translation (GO:0070129) | 3.95060024 |
34 | regulation of synaptic vesicle exocytosis (GO:2000300) | 3.93467745 |
35 | ATP hydrolysis coupled proton transport (GO:0015991) | 3.91481749 |
36 | energy coupled proton transmembrane transport, against electrochemical gradient (GO:0015988) | 3.91481749 |
37 | anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process (GO:0 | 3.90271162 |
38 | presynaptic membrane organization (GO:0097090) | 3.89220317 |
39 | protein neddylation (GO:0045116) | 3.89066822 |
40 | transferrin transport (GO:0033572) | 3.87667670 |
41 | postsynaptic membrane organization (GO:0001941) | 3.87572015 |
42 | negative regulation of synaptic transmission, GABAergic (GO:0032229) | 3.84168800 |
43 | mitochondrial ATP synthesis coupled proton transport (GO:0042776) | 3.82270283 |
44 | mitochondrial electron transport, NADH to ubiquinone (GO:0006120) | 3.79573147 |
45 | regulation of glutamate receptor signaling pathway (GO:1900449) | 3.74296238 |
46 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 3.74184071 |
47 | glutamate secretion (GO:0014047) | 3.67513406 |
48 | positive regulation of ubiquitin-protein transferase activity (GO:0051443) | 3.65133748 |
49 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent (GO: | 3.63504326 |
50 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 3.62637514 |
51 | metallo-sulfur cluster assembly (GO:0031163) | 3.61436839 |
52 | iron-sulfur cluster assembly (GO:0016226) | 3.61436839 |
53 | rRNA modification (GO:0000154) | 3.58430248 |
54 | cullin deneddylation (GO:0010388) | 3.58249679 |
55 | peptidyl-histidine modification (GO:0018202) | 3.55745475 |
56 | trivalent inorganic cation transport (GO:0072512) | 3.55688212 |
57 | ferric iron transport (GO:0015682) | 3.55688212 |
58 | energy coupled proton transport, down electrochemical gradient (GO:0015985) | 3.55640630 |
59 | ATP synthesis coupled proton transport (GO:0015986) | 3.55640630 |
60 | negative regulation of dendrite development (GO:2000171) | 3.55567215 |
61 | spliceosomal snRNP assembly (GO:0000387) | 3.55353850 |
62 | regulation of cellular amine metabolic process (GO:0033238) | 3.55294820 |
63 | neuron-neuron synaptic transmission (GO:0007270) | 3.53949980 |
64 | regulation of synaptic vesicle transport (GO:1902803) | 3.53589178 |
65 | protein targeting to mitochondrion (GO:0006626) | 3.52113442 |
66 | pseudouridine synthesis (GO:0001522) | 3.50694412 |
67 | positive regulation of mitochondrial fission (GO:0090141) | 3.50279769 |
68 | positive regulation of ligase activity (GO:0051351) | 3.48468758 |
69 | regulation of glutamate secretion (GO:0014048) | 3.45519891 |
70 | establishment of protein localization to mitochondrion (GO:0072655) | 3.45081774 |
71 | startle response (GO:0001964) | 3.44130350 |
72 | GDP-mannose metabolic process (GO:0019673) | 3.43176059 |
73 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 3.42819300 |
74 | neurotransmitter-gated ion channel clustering (GO:0072578) | 3.42650530 |
75 | ATP biosynthetic process (GO:0006754) | 3.41339394 |
76 | regulation of atrial cardiac muscle cell membrane depolarization (GO:0060371) | 3.39320287 |
77 | hydrogen ion transmembrane transport (GO:1902600) | 3.38745938 |
78 | DNA damage response, signal transduction by p53 class mediator (GO:0030330) | 3.37810933 |
79 | synaptic transmission, glutamatergic (GO:0035249) | 3.36600074 |
80 | purine nucleoside triphosphate biosynthetic process (GO:0009145) | 3.36410405 |
81 | inositol phosphate catabolic process (GO:0071545) | 3.36204345 |
82 | purine ribonucleoside triphosphate biosynthetic process (GO:0009206) | 3.35664969 |
83 | maturation of 5.8S rRNA (GO:0000460) | 3.33828725 |
84 | antigen processing and presentation of exogenous peptide antigen via MHC class I (GO:0042590) | 3.33430201 |
85 | RNA splicing, via endonucleolytic cleavage and ligation (GO:0000394) | 3.32932026 |
86 | tRNA splicing, via endonucleolytic cleavage and ligation (GO:0006388) | 3.32932026 |
87 | protein complex biogenesis (GO:0070271) | 3.31825090 |
88 | positive regulation of synapse assembly (GO:0051965) | 3.30098523 |
89 | ribosomal small subunit assembly (GO:0000028) | 3.27854325 |
90 | protein deneddylation (GO:0000338) | 3.25988806 |
91 | positive regulation of cell cycle arrest (GO:0071158) | 3.25705502 |
92 | neurotransmitter secretion (GO:0007269) | 3.25089250 |
93 | base-excision repair, AP site formation (GO:0006285) | 3.24663184 |
94 | establishment of viral latency (GO:0019043) | 3.23831774 |
95 | regulation of ubiquitin-protein transferase activity (GO:0051438) | 3.23005473 |
96 | ionotropic glutamate receptor signaling pathway (GO:0035235) | 3.22191905 |
97 | gamma-aminobutyric acid signaling pathway (GO:0007214) | 3.20545782 |
98 | protein localization to mitochondrion (GO:0070585) | 3.18947447 |
99 | GTP biosynthetic process (GO:0006183) | 3.17695954 |
100 | deoxyribonucleoside monophosphate metabolic process (GO:0009162) | 3.13505757 |
101 | mannosylation (GO:0097502) | 3.10991713 |
102 | regulation of ligase activity (GO:0051340) | 3.10801055 |
103 | glutamate receptor signaling pathway (GO:0007215) | 3.09224174 |
104 | positive regulation of neurotransmitter transport (GO:0051590) | 3.08397353 |
105 | ribonucleoside triphosphate biosynthetic process (GO:0009201) | 3.06738265 |
106 | serotonin receptor signaling pathway (GO:0007210) | 3.05410773 |
107 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 3.05099321 |
108 | proton transport (GO:0015992) | 3.04936416 |
109 | purine deoxyribonucleotide catabolic process (GO:0009155) | 3.03024230 |
110 | respiratory electron transport chain (GO:0022904) | 3.02374553 |
111 | long-term synaptic potentiation (GO:0060291) | 3.02262472 |
112 | nuclear-transcribed mRNA catabolic process, exonucleolytic (GO:0000291) | 3.02215978 |
113 | transmission of nerve impulse (GO:0019226) | 3.02048927 |
114 | * negative regulation of protein ubiquitination (GO:0031397) | 3.00767653 |
115 | DNA damage response, detection of DNA damage (GO:0042769) | 3.00460073 |
116 | establishment of integrated proviral latency (GO:0075713) | 2.99404461 |
117 | hydrogen transport (GO:0006818) | 2.98228477 |
118 | regulation of protein kinase A signaling (GO:0010738) | 2.97013918 |
119 | guanosine-containing compound biosynthetic process (GO:1901070) | 2.96761746 |
120 | neurofilament cytoskeleton organization (GO:0060052) | 2.96609593 |
121 | electron transport chain (GO:0022900) | 2.96402422 |
122 | female mating behavior (GO:0060180) | 2.96352085 |
123 | regulation of excitatory postsynaptic membrane potential (GO:0060079) | 2.95328232 |
124 | positive regulation of neurotransmitter secretion (GO:0001956) | 2.93967948 |
125 | phagosome maturation (GO:0090382) | 2.93049905 |
126 | GMP metabolic process (GO:0046037) | 2.92785862 |
127 | aldehyde catabolic process (GO:0046185) | 2.92055874 |
128 | mitochondrial respiratory chain complex I assembly (GO:0032981) | 2.90786744 |
129 | NADH dehydrogenase complex assembly (GO:0010257) | 2.90786744 |
130 | mitochondrial respiratory chain complex I biogenesis (GO:0097031) | 2.90786744 |
131 | intracellular protein transmembrane import (GO:0044743) | 2.90434538 |
132 | protein localization to cilium (GO:0061512) | 2.90320145 |
133 | exonucleolytic nuclear-transcribed mRNA catabolic process involved in deadenylation-dependent decay | 2.90061735 |
134 | neurotransmitter uptake (GO:0001504) | 2.89995554 |
135 | regulation of catecholamine uptake involved in synaptic transmission (GO:0051940) | 2.89737250 |
136 | regulation of dopamine uptake involved in synaptic transmission (GO:0051584) | 2.89737250 |
137 | regulation of cell cycle arrest (GO:0071156) | 2.89119662 |
138 | signal transduction in response to DNA damage (GO:0042770) | 2.88614006 |
139 | mitochondrial respiratory chain complex assembly (GO:0033108) | 2.88590806 |
140 | UTP biosynthetic process (GO:0006228) | 2.87936909 |
141 | behavioral response to nicotine (GO:0035095) | 2.87532879 |
142 | regulation of long-term neuronal synaptic plasticity (GO:0048169) | 2.87423213 |
143 | striatum development (GO:0021756) | 2.87146659 |
144 | dopamine transport (GO:0015872) | 2.86877617 |
145 | * negative regulation of protein modification by small protein conjugation or removal (GO:1903321) | 2.86463604 |
146 | translation (GO:0006412) | 2.85948628 |
147 | regulation of neuronal synaptic plasticity (GO:0048168) | 2.85919859 |
148 | nuclear envelope reassembly (GO:0031468) | 2.85907213 |
149 | mitotic nuclear envelope reassembly (GO:0007084) | 2.85907213 |
150 | pyrimidine deoxyribonucleotide catabolic process (GO:0009223) | 2.84826703 |
151 | positive regulation of synaptic transmission, GABAergic (GO:0032230) | 2.84268408 |
152 | deoxyribonucleotide catabolic process (GO:0009264) | 2.84089725 |
153 | positive regulation of amino acid transport (GO:0051957) | 2.83955923 |
154 | oxidative phosphorylation (GO:0006119) | 2.82947649 |
155 | opioid receptor signaling pathway (GO:0038003) | 2.81181617 |
156 | regulation of neurotransmitter secretion (GO:0046928) | 2.80951062 |
157 | negative regulation of synaptic transmission, glutamatergic (GO:0051967) | 2.80943435 |
158 | neuron recognition (GO:0008038) | 2.80908521 |
159 | cellular component biogenesis (GO:0044085) | 2.80772217 |
160 | protein maturation by protein folding (GO:0022417) | 2.80726782 |
161 | water-soluble vitamin biosynthetic process (GO:0042364) | 2.80645386 |
162 | regulation of postsynaptic membrane potential (GO:0060078) | 2.80545762 |
163 | dendrite development (GO:0016358) | 2.80033949 |
164 | positive regulation of cellular response to oxidative stress (GO:1900409) | 2.79678108 |
165 | positive regulation of response to oxidative stress (GO:1902884) | 2.79678108 |
166 | cell migration in hindbrain (GO:0021535) | 2.79663370 |
167 | response to histamine (GO:0034776) | 2.76581087 |
168 | regulation of synaptic transmission, GABAergic (GO:0032228) | 2.76051688 |
169 | neurotransmitter transport (GO:0006836) | 2.75895065 |
170 | innervation (GO:0060384) | 2.74972675 |
171 | regulation of female receptivity (GO:0045924) | 2.73846543 |
172 | protein-cofactor linkage (GO:0018065) | 2.73484416 |
173 | regulation of mitochondrial fission (GO:0090140) | 2.70114296 |
174 | positive regulation of membrane potential (GO:0045838) | 2.69408888 |
175 | synaptic transmission, dopaminergic (GO:0001963) | 2.67684468 |
176 | synaptic vesicle maturation (GO:0016188) | 2.66655671 |
177 | regulation of synaptic transmission, glutamatergic (GO:0051966) | 2.65751822 |
178 | regulation of neurotransmitter transport (GO:0051588) | 2.65289977 |
179 | behavioral fear response (GO:0001662) | 2.65007300 |
180 | behavioral defense response (GO:0002209) | 2.65007300 |
181 | mitochondrial fragmentation involved in apoptotic process (GO:0043653) | 2.63313016 |
182 | regulation of inhibitory postsynaptic membrane potential (GO:0060080) | 2.61693094 |
183 | exploration behavior (GO:0035640) | 2.61230481 |
Rank | Gene Set | Z-score |
---|---|---|
1 | EZH2_22144423_ChIP-Seq_EOC_Human | 5.44115540 |
2 | GBX2_23144817_ChIP-Seq_PC3_Human | 4.23018308 |
3 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 2.91659800 |
4 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 2.90867279 |
5 | TAF15_26573619_Chip-Seq_HEK293_Human | 2.90770081 |
6 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 2.82899967 |
7 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 2.79189211 |
8 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 2.73248090 |
9 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 2.69849557 |
10 | * MYC_18358816_ChIP-ChIP_MESCs_Mouse | 2.68122833 |
11 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 2.66842050 |
12 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 2.53009759 |
13 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 2.50174565 |
14 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 2.46620125 |
15 | * EZH2_27304074_Chip-Seq_ESCs_Mouse | 2.45290434 |
16 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 2.40087942 |
17 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 2.39915406 |
18 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 2.36660457 |
19 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 2.33294198 |
20 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 2.29954426 |
21 | REST_21632747_ChIP-Seq_MESCs_Mouse | 2.29365194 |
22 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 2.28671318 |
23 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 2.28671318 |
24 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 2.28371840 |
25 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 2.26491795 |
26 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 2.25754903 |
27 | XRN2_22483619_ChIP-Seq_HELA_Human | 2.24779036 |
28 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 2.22429957 |
29 | * GABP_19822575_ChIP-Seq_HepG2_Human | 2.19666327 |
30 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 2.19095259 |
31 | VDR_23849224_ChIP-Seq_CD4+_Human | 2.16494601 |
32 | FOXP3_21729870_ChIP-Seq_TREG_Human | 2.12649312 |
33 | * MYC_19030024_ChIP-ChIP_MESCs_Mouse | 2.08857419 |
34 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 2.05456166 |
35 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 2.05385652 |
36 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.97120773 |
37 | DCP1A_22483619_ChIP-Seq_HELA_Human | 1.96339896 |
38 | * E2F1_18555785_ChIP-Seq_MESCs_Mouse | 1.95711515 |
39 | RNF2_27304074_Chip-Seq_NSC_Mouse | 1.87786845 |
40 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.86436899 |
41 | P300_19829295_ChIP-Seq_ESCs_Human | 1.84293984 |
42 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 1.83498667 |
43 | CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 1.82305422 |
44 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 1.82238549 |
45 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 1.81084565 |
46 | * CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 1.80543334 |
47 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.78532870 |
48 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.77335306 |
49 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.77020132 |
50 | VDR_22108803_ChIP-Seq_LS180_Human | 1.75051041 |
51 | * RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.73191823 |
52 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 1.72714987 |
53 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 1.72607706 |
54 | TTF2_22483619_ChIP-Seq_HELA_Human | 1.71595314 |
55 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.70366056 |
56 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.68388467 |
57 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.67362124 |
58 | FUS_26573619_Chip-Seq_HEK293_Human | 1.65571906 |
59 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.62632962 |
60 | * SIN3A_21632747_ChIP-Seq_MESCs_Mouse | 1.61877664 |
61 | * RARB_27405468_Chip-Seq_BRAIN_Mouse | 1.61534555 |
62 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.59615669 |
63 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 1.58226835 |
64 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.57551809 |
65 | * EBNA2_21746931_ChIP-Seq_IB4-LCL_Human | 1.56488298 |
66 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.55384845 |
67 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 1.52937670 |
68 | THAP11_20581084_ChIP-Seq_MESCs_Mouse | 1.52794811 |
69 | * TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.51611150 |
70 | * NELFA_20434984_ChIP-Seq_ESCs_Mouse | 1.50340964 |
71 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.49341929 |
72 | CTCF_18555785_ChIP-Seq_MESCs_Mouse | 1.47350628 |
73 | FOXP2_21765815_ChIP-ChIP_NEURO2A_Mouse | 1.46816644 |
74 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.45920180 |
75 | * KDM5A_27292631_Chip-Seq_BREAST_Human | 1.44775780 |
76 | DMRT1_21621532_ChIP-ChIP_FETAL_Ovary | 1.44544777 |
77 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.43820803 |
78 | * SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.43801891 |
79 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 1.42333147 |
80 | * ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.41358208 |
81 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.39699340 |
82 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.39262160 |
83 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.38294531 |
84 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 1.37030425 |
85 | FOXP1_21924763_ChIP-Seq_HESCs_Human | 1.36970833 |
86 | * P68_20966046_ChIP-Seq_HELA_Human | 1.35889788 |
87 | * JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 1.35382365 |
88 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.35190266 |
89 | YY1_21170310_ChIP-Seq_MESCs_Mouse | 1.34934573 |
90 | * BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 1.34427049 |
91 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.33783186 |
92 | JUN_21703547_ChIP-Seq_K562_Human | 1.33254870 |
93 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.33209994 |
94 | * RBPJ_21746931_ChIP-Seq_IB4-LCL_Human | 1.33114099 |
95 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 1.31629007 |
96 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.31241098 |
97 | POU5F1_16153702_ChIP-ChIP_HESCs_Human | 1.30171830 |
98 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.29826401 |
99 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 1.29812637 |
100 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.29508703 |
101 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.29193785 |
102 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 1.28322497 |
103 | MYC_18940864_ChIP-ChIP_HL60_Human | 1.27039815 |
104 | MYC_20876797_ChIP-ChIP_MEDULLOBLASTOMA_Human | 1.26553178 |
105 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.25469168 |
106 | CEBPB_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.24143882 |
107 | YY1_22570637_ChIP-Seq_MALME-3M_Human | 1.23376203 |
108 | * YY1_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.22958446 |
109 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 1.22046257 |
110 | CTCF_26484167_Chip-Seq_Bcells_Mouse | 1.21793027 |
111 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.21369269 |
112 | NANOG_18555785_ChIP-Seq_MESCs_Mouse | 1.19854486 |
113 | * BCOR_27268052_Chip-Seq_Bcells_Human | 1.18218292 |
114 | SOX9_26525672_Chip-Seq_HEART_Mouse | 1.15753831 |
115 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.14850950 |
116 | EWS_26573619_Chip-Seq_HEK293_Human | 1.14565204 |
117 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.14389386 |
118 | CRX_20693478_ChIP-Seq_ADULT_RETINA_Mouse | 1.14324319 |
119 | * FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 1.13895288 |
120 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 1.13825512 |
121 | POU5F1_18358816_ChIP-ChIP_MESCs_Mouse | 1.13750864 |
122 | POU5F1_18555785_ChIP-Seq_MESCs_Mouse | 1.12279719 |
123 | CTCF_20526341_ChIP-Seq_ESCs_Human | 1.11272251 |
124 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 1.08731497 |
125 | RARB_24833708_ChIP-Seq_LIVER_Mouse | 1.08452039 |
126 | * PHF8_20622854_ChIP-Seq_HELA_Human | 1.08367854 |
127 | * AR_25329375_ChIP-Seq_VCAP_Human | 1.08283237 |
128 | E2F1_20622854_ChIP-Seq_HELA_Human | 1.07770090 |
129 | MYBL2_22936984_ChIP-ChIP_MESCs_Mouse | 1.07720964 |
130 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.07688843 |
131 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.07188779 |
132 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 1.06837047 |
133 | ELK1_19687146_ChIP-ChIP_HELA_Human | 1.06562536 |
134 | PAX6_23342162_ChIP-ChIP_BETA-FORBRAIN-LENS_Mouse | 1.04929489 |
135 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.04123820 |
136 | * SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.02912273 |
137 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.02672212 |
138 | SA1_27219007_Chip-Seq_Bcells_Human | 1.00879360 |
139 | * FLI1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.00435643 |
140 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 1.00399522 |
141 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.00042066 |
142 | AR_21572438_ChIP-Seq_LNCaP_Human | 0.99959110 |
143 | * SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 0.97179135 |
144 | SOX2_16153702_ChIP-ChIP_HESCs_Human | 0.96227642 |
145 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 0.95700963 |
146 | SETDB1_19884255_ChIP-Seq_MESCs_Mouse | 0.94860294 |
147 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.94769739 |
148 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 0.93653826 |
149 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 0.93620870 |
150 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 0.93416233 |
151 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.93401416 |
152 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 0.92923044 |
153 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 0.92767867 |
154 | * MYCN_18555785_ChIP-Seq_MESCs_Mouse | 0.92098130 |
155 | RUNX2_22187159_ChIP-Seq_PCA_Human | 0.91716349 |
156 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 0.90799608 |
157 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 0.90556907 |
158 | * ZFX_18555785_ChIP-Seq_MESCs_Mouse | 0.90554980 |
159 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 0.90360710 |
160 | ZNF274_21170338_ChIP-Seq_K562_Hela | 0.90353574 |
161 | ZFP42_18358816_ChIP-ChIP_MESCs_Mouse | 0.90346900 |
162 | E2F4_21247883_ChIP-Seq_LYMPHOBLASTOID_Human | 0.90307929 |
163 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 0.90177697 |
164 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.89992645 |
165 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 0.89990601 |
166 | TBX5_21415370_ChIP-Seq_HL-1_Mouse | 0.89782251 |
167 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 0.89581317 |
168 | CEBPB_26923725_Chip-Seq_MESODERM_Mouse | 0.89090251 |
169 | * SIN3B_21632747_ChIP-Seq_MESCs_Mouse | 0.87513752 |
170 | IRF1_19129219_ChIP-ChIP_H3396_Human | 0.85736719 |
171 | RCOR2_21632747_ChIP-Seq_MESCs_Mouse | 0.84497174 |
172 | TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.84454525 |
173 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 0.84445298 |
174 | * SOX2_21211035_ChIP-Seq_LN229_Gbm | 0.84150437 |
175 | P53_22387025_ChIP-Seq_ESCs_Mouse | 0.82357827 |
176 | GRHL2_25758223_ChIP-Seq_PLACENTA_Mouse | 0.82292370 |
177 | EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 0.81936507 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MP0003880_abnormal_central_pattern | 5.05716714 |
2 | MP0004859_abnormal_synaptic_plasticity | 3.74346088 |
3 | MP0001968_abnormal_touch/_nociception | 3.29805614 |
4 | MP0003635_abnormal_synaptic_transmissio | 3.22081758 |
5 | MP0002736_abnormal_nociception_after | 3.18755446 |
6 | MP0009046_muscle_twitch | 3.08861127 |
7 | MP0009745_abnormal_behavioral_response | 3.02776934 |
8 | MP0003806_abnormal_nucleotide_metabolis | 3.00764763 |
9 | MP0002735_abnormal_chemical_nociception | 2.98553320 |
10 | MP0004270_analgesia | 2.95104725 |
11 | MP0002064_seizures | 2.86213165 |
12 | MP0006276_abnormal_autonomic_nervous | 2.82065797 |
13 | MP0003693_abnormal_embryo_hatching | 2.77277437 |
14 | MP0002063_abnormal_learning/memory/cond | 2.73392284 |
15 | MP0001529_abnormal_vocalization | 2.66111049 |
16 | MP0002272_abnormal_nervous_system | 2.58233287 |
17 | MP0002572_abnormal_emotion/affect_behav | 2.55448019 |
18 | MP0002734_abnormal_mechanical_nocicepti | 2.45669185 |
19 | MP0003122_maternal_imprinting | 2.38033658 |
20 | MP0005646_abnormal_pituitary_gland | 2.20076045 |
21 | MP0001188_hyperpigmentation | 2.15723480 |
22 | MP0001905_abnormal_dopamine_level | 2.12704312 |
23 | MP0008058_abnormal_DNA_repair | 2.11460269 |
24 | MP0002067_abnormal_sensory_capabilities | 2.05086051 |
25 | MP0002822_catalepsy | 2.00901346 |
26 | MP0004142_abnormal_muscle_tone | 2.00581902 |
27 | MP0001486_abnormal_startle_reflex | 1.99446953 |
28 | MP0001970_abnormal_pain_threshold | 1.94393115 |
29 | MP0006036_abnormal_mitochondrial_physio | 1.93782322 |
30 | MP0003786_premature_aging | 1.90795544 |
31 | MP0005075_abnormal_melanosome_morpholog | 1.90075148 |
32 | MP0002733_abnormal_thermal_nociception | 1.89890421 |
33 | MP0001984_abnormal_olfaction | 1.89787510 |
34 | MP0001501_abnormal_sleep_pattern | 1.85628899 |
35 | MP0001440_abnormal_grooming_behavior | 1.85098433 |
36 | MP0002184_abnormal_innervation | 1.83594920 |
37 | MP0003787_abnormal_imprinting | 1.81840978 |
38 | MP0002277_abnormal_respiratory_mucosa | 1.79532071 |
39 | MP0005671_abnormal_response_to | 1.74747337 |
40 | MP0002876_abnormal_thyroid_physiology | 1.73634715 |
41 | MP0001873_stomach_inflammation | 1.71672505 |
42 | MP0002557_abnormal_social/conspecific_i | 1.65595754 |
43 | MP0000778_abnormal_nervous_system | 1.64018660 |
44 | MP0002254_reproductive_system_inflammat | 1.62325034 |
45 | MP0001346_abnormal_lacrimal_gland | 1.62175294 |
46 | MP0005394_taste/olfaction_phenotype | 1.59393299 |
47 | MP0005499_abnormal_olfactory_system | 1.59393299 |
48 | MP0010030_abnormal_orbit_morphology | 1.55585066 |
49 | MP0005386_behavior/neurological_phenoty | 1.55026327 |
50 | MP0004924_abnormal_behavior | 1.55026327 |
51 | MP0009333_abnormal_splenocyte_physiolog | 1.53352455 |
52 | MP0008875_abnormal_xenobiotic_pharmacok | 1.51948114 |
53 | MP0005310_abnormal_salivary_gland | 1.50740849 |
54 | MP0004133_heterotaxia | 1.49339336 |
55 | MP0002751_abnormal_autonomic_nervous | 1.48167063 |
56 | MP0004957_abnormal_blastocyst_morpholog | 1.48122371 |
57 | MP0003111_abnormal_nucleus_morphology | 1.47425816 |
58 | MP0005423_abnormal_somatic_nervous | 1.46978285 |
59 | MP0003718_maternal_effect | 1.45324465 |
60 | MP0005645_abnormal_hypothalamus_physiol | 1.44760742 |
61 | MP0001986_abnormal_taste_sensitivity | 1.44337872 |
62 | MP0003011_delayed_dark_adaptation | 1.42040875 |
63 | MP0002102_abnormal_ear_morphology | 1.41154771 |
64 | MP0008789_abnormal_olfactory_epithelium | 1.40505640 |
65 | MP0004811_abnormal_neuron_physiology | 1.39387543 |
66 | MP0004858_abnormal_nervous_system | 1.39047873 |
67 | MP0008569_lethality_at_weaning | 1.37283209 |
68 | MP0002938_white_spotting | 1.33900960 |
69 | MP0000955_abnormal_spinal_cord | 1.33273541 |
70 | MP0008007_abnormal_cellular_replicative | 1.32673691 |
71 | MP0006072_abnormal_retinal_apoptosis | 1.31470173 |
72 | MP0002882_abnormal_neuron_morphology | 1.30319629 |
73 | MP0010094_abnormal_chromosome_stability | 1.29949448 |
74 | MP0005171_absent_coat_pigmentation | 1.29824880 |
75 | MP0002653_abnormal_ependyma_morphology | 1.29042873 |
76 | MP0003879_abnormal_hair_cell | 1.28755909 |
77 | MP0003186_abnormal_redox_activity | 1.26552236 |
78 | MP0005377_hearing/vestibular/ear_phenot | 1.23398988 |
79 | MP0003878_abnormal_ear_physiology | 1.23398988 |
80 | MP0002066_abnormal_motor_capabilities/c | 1.23281730 |
81 | MP0006292_abnormal_olfactory_placode | 1.22817178 |
82 | MP0002234_abnormal_pharynx_morphology | 1.20528719 |
83 | MP0008877_abnormal_DNA_methylation | 1.17238737 |
84 | MP0001963_abnormal_hearing_physiology | 1.14717655 |
85 | MP0002837_dystrophic_cardiac_calcinosis | 1.12429538 |
86 | MP0003121_genomic_imprinting | 1.11476916 |
87 | MP0010386_abnormal_urinary_bladder | 1.09984421 |
88 | MP0005409_darkened_coat_color | 1.09972769 |
89 | MP0000631_abnormal_neuroendocrine_gland | 1.07564519 |
90 | MP0002148_abnormal_hypersensitivity_rea | 1.04141575 |
91 | MP0001764_abnormal_homeostasis | 1.03850149 |
92 | MP0008932_abnormal_embryonic_tissue | 1.03535612 |
93 | MP0002638_abnormal_pupillary_reflex | 1.03092385 |
94 | MP0002163_abnormal_gland_morphology | 1.02830613 |
95 | MP0001502_abnormal_circadian_rhythm | 1.00721824 |
96 | MP0004742_abnormal_vestibular_system | 1.00144385 |
97 | MP0000026_abnormal_inner_ear | 0.99534237 |
98 | MP0000538_abnormal_urinary_bladder | 0.98175467 |
99 | MP0002752_abnormal_somatic_nervous | 0.98138955 |
100 | MP0002152_abnormal_brain_morphology | 0.94789176 |
101 | MP0001919_abnormal_reproductive_system | 0.91178655 |
102 | MP0000372_irregular_coat_pigmentation | 0.90555365 |
103 | MP0003077_abnormal_cell_cycle | 0.90241070 |
104 | MP0002229_neurodegeneration | 0.88876055 |
105 | MP0002693_abnormal_pancreas_physiology | 0.88808399 |
106 | MP0000537_abnormal_urethra_morphology | 0.86030254 |
107 | MP0008872_abnormal_physiological_respon | 0.85861112 |
108 | MP0008961_abnormal_basal_metabolism | 0.85809520 |
109 | MP0001485_abnormal_pinna_reflex | 0.84820984 |
110 | MP0009780_abnormal_chondrocyte_physiolo | 0.84072912 |
111 | MP0000751_myopathy | 0.83688016 |
112 | MP0003137_abnormal_impulse_conducting | 0.83538095 |
113 | MP0003136_yellow_coat_color | 0.83184555 |
114 | MP0009379_abnormal_foot_pigmentation | 0.81109562 |
115 | MP0006035_abnormal_mitochondrial_morpho | 0.81029374 |
116 | MP0000015_abnormal_ear_pigmentation | 0.80500585 |
117 | MP0003938_abnormal_ear_development | 0.80251143 |
118 | MP0003329_amyloid_beta_deposits | 0.78493791 |
119 | MP0008995_early_reproductive_senescence | 0.77506994 |
120 | MP0001293_anophthalmia | 0.77309981 |
121 | MP0000358_abnormal_cell_content/ | 0.77270107 |
122 | MP0008260_abnormal_autophagy | 0.77250884 |
123 | MP0005084_abnormal_gallbladder_morpholo | 0.75447395 |
124 | MP0004085_abnormal_heartbeat | 0.74652021 |
125 | MP0002160_abnormal_reproductive_system | 0.74109827 |
126 | MP0002069_abnormal_eating/drinking_beha | 0.72982365 |
127 | MP0000049_abnormal_middle_ear | 0.72541308 |
128 | MP0005253_abnormal_eye_physiology | 0.72307351 |
129 | MP0003123_paternal_imprinting | 0.72028317 |
130 | MP0003631_nervous_system_phenotype | 0.70596138 |
131 | MP0004145_abnormal_muscle_electrophysio | 0.67953285 |
132 | MP0003646_muscle_fatigue | 0.66973033 |
133 | MP0002210_abnormal_sex_determination | 0.66389644 |
134 | MP0001664_abnormal_digestion | 0.65597277 |
135 | MP0003315_abnormal_perineum_morphology | 0.64782286 |
136 | MP0000681_abnormal_thyroid_gland | 0.64726325 |
137 | MP0001348_abnormal_lacrimal_gland | 0.64546394 |
138 | MP0002090_abnormal_vision | 0.64146209 |
139 | MP0003698_abnormal_male_reproductive | 0.64123731 |
140 | MP0000566_synostosis | 0.60756321 |
141 | MP0003633_abnormal_nervous_system | 0.60371586 |
142 | MP0005551_abnormal_eye_electrophysiolog | 0.59682318 |
143 | MP0001943_abnormal_respiration | 0.58419808 |
144 | MP0005379_endocrine/exocrine_gland_phen | 0.57780285 |
145 | MP0004147_increased_porphyrin_level | 0.57495547 |
146 | MP0001177_atelectasis | 0.57288415 |
147 | MP0004885_abnormal_endolymph | 0.56999292 |
148 | MP0002332_abnormal_exercise_endurance | 0.54713369 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Focal motor seizures (HP:0011153) | 6.46644703 |
2 | Atonic seizures (HP:0010819) | 5.22343676 |
3 | Febrile seizures (HP:0002373) | 4.91161553 |
4 | Myokymia (HP:0002411) | 4.51684560 |
5 | Acute necrotizing encephalopathy (HP:0006965) | 4.48411976 |
6 | Epileptic encephalopathy (HP:0200134) | 4.31766122 |
7 | Abnormal mitochondria in muscle tissue (HP:0008316) | 4.09394317 |
8 | Mitochondrial inheritance (HP:0001427) | 4.02036309 |
9 | Abnormal hair whorl (HP:0010721) | 3.95652758 |
10 | Progressive macrocephaly (HP:0004481) | 3.84016081 |
11 | Focal seizures (HP:0007359) | 3.79788161 |
12 | Hepatocellular necrosis (HP:0001404) | 3.67206105 |
13 | Hypothermia (HP:0002045) | 3.58627013 |
14 | Testicular atrophy (HP:0000029) | 3.57982784 |
15 | Pheochromocytoma (HP:0002666) | 3.50600349 |
16 | Increased CSF lactate (HP:0002490) | 3.49303739 |
17 | Hyperventilation (HP:0002883) | 3.41001682 |
18 | Neuroendocrine neoplasm (HP:0100634) | 3.37979542 |
19 | Absence seizures (HP:0002121) | 3.36870330 |
20 | Acute encephalopathy (HP:0006846) | 3.20504623 |
21 | Abnormal number of erythroid precursors (HP:0012131) | 3.20198686 |
22 | Increased intramyocellular lipid droplets (HP:0012240) | 3.19444298 |
23 | Gait imbalance (HP:0002141) | 3.17898869 |
24 | Lipid accumulation in hepatocytes (HP:0006561) | 3.16374195 |
25 | Dialeptic seizures (HP:0011146) | 3.15691008 |
26 | Medial flaring of the eyebrow (HP:0010747) | 3.08994918 |
27 | Congenital primary aphakia (HP:0007707) | 3.07507088 |
28 | Failure to thrive in infancy (HP:0001531) | 3.03363933 |
29 | Nephrogenic diabetes insipidus (HP:0009806) | 3.01953495 |
30 | Type I transferrin isoform profile (HP:0003642) | 3.00542962 |
31 | Progressive cerebellar ataxia (HP:0002073) | 2.99525984 |
32 | Aplastic anemia (HP:0001915) | 2.98898139 |
33 | Cerebral edema (HP:0002181) | 2.96516780 |
34 | Visual hallucinations (HP:0002367) | 2.92958514 |
35 | Methylmalonic aciduria (HP:0012120) | 2.90379654 |
36 | Poor suck (HP:0002033) | 2.89557163 |
37 | Microretrognathia (HP:0000308) | 2.89396996 |
38 | Increased muscle lipid content (HP:0009058) | 2.80394608 |
39 | Increased serum pyruvate (HP:0003542) | 2.79219266 |
40 | Abnormality of glycolysis (HP:0004366) | 2.79219266 |
41 | Optic disc pallor (HP:0000543) | 2.71563196 |
42 | Generalized tonic-clonic seizures (HP:0002069) | 2.61173374 |
43 | Abnormality of cells of the erythroid lineage (HP:0012130) | 2.61057004 |
44 | Amblyopia (HP:0000646) | 2.60312996 |
45 | Abnormal isoelectric focusing of serum transferrin (HP:0003160) | 2.58140435 |
46 | Abnormal protein N-linked glycosylation (HP:0012347) | 2.58140435 |
47 | Abnormal protein glycosylation (HP:0012346) | 2.58140435 |
48 | Abnormal glycosylation (HP:0012345) | 2.58140435 |
49 | Hepatic necrosis (HP:0002605) | 2.57276810 |
50 | Narrow nasal bridge (HP:0000446) | 2.44292933 |
51 | Polyphagia (HP:0002591) | 2.42635112 |
52 | Genital tract atresia (HP:0001827) | 2.41234315 |
53 | Broad-based gait (HP:0002136) | 2.40837032 |
54 | Vaginal atresia (HP:0000148) | 2.39734711 |
55 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 2.37025502 |
56 | Abnormality of alanine metabolism (HP:0010916) | 2.37025502 |
57 | Hyperalaninemia (HP:0003348) | 2.37025502 |
58 | Abnormality of the labia minora (HP:0012880) | 2.35409671 |
59 | Limb dystonia (HP:0002451) | 2.34966418 |
60 | Methylmalonic acidemia (HP:0002912) | 2.34901860 |
61 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.30129166 |
62 | Dicarboxylic aciduria (HP:0003215) | 2.30129166 |
63 | Progressive microcephaly (HP:0000253) | 2.29134741 |
64 | Poor coordination (HP:0002370) | 2.26556438 |
65 | Pancreatic cysts (HP:0001737) | 2.23803622 |
66 | Fetal akinesia sequence (HP:0001989) | 2.21907507 |
67 | Specific learning disability (HP:0001328) | 2.21593729 |
68 | Degeneration of the lateral corticospinal tracts (HP:0002314) | 2.20495272 |
69 | Atrophy/Degeneration involving the corticospinal tracts (HP:0007372) | 2.20495272 |
70 | Respiratory failure (HP:0002878) | 2.20457777 |
71 | Microvesicular hepatic steatosis (HP:0001414) | 2.19784613 |
72 | Pancytopenia (HP:0001876) | 2.17687604 |
73 | Lethargy (HP:0001254) | 2.17155784 |
74 | CNS hypomyelination (HP:0003429) | 2.17074883 |
75 | Delusions (HP:0000746) | 2.17009053 |
76 | Exercise intolerance (HP:0003546) | 2.16897649 |
77 | Abnormal eating behavior (HP:0100738) | 2.15684571 |
78 | Lactic acidosis (HP:0003128) | 2.13944844 |
79 | Muscle abnormality related to mitochondrial dysfunction (HP:0003800) | 2.12397044 |
80 | Anxiety (HP:0000739) | 2.11827319 |
81 | Leukodystrophy (HP:0002415) | 2.10038637 |
82 | Abnormality of midbrain morphology (HP:0002418) | 2.09492610 |
83 | Molar tooth sign on MRI (HP:0002419) | 2.09492610 |
84 | Opisthotonus (HP:0002179) | 2.08553030 |
85 | Esotropia (HP:0000565) | 2.08091447 |
86 | Sleep apnea (HP:0010535) | 2.07854130 |
87 | Increased serum lactate (HP:0002151) | 2.07611492 |
88 | Decreased activity of cytochrome C oxidase in muscle tissue (HP:0003688) | 2.06897249 |
89 | Exertional dyspnea (HP:0002875) | 2.05677917 |
90 | 3-Methylglutaconic aciduria (HP:0003535) | 2.04626384 |
91 | Decreased activity of mitochondrial respiratory chain (HP:0008972) | 2.03267455 |
92 | Abnormal activity of mitochondrial respiratory chain (HP:0011922) | 2.03267455 |
93 | True hermaphroditism (HP:0010459) | 2.03259990 |
94 | Gaze-evoked nystagmus (HP:0000640) | 2.02414711 |
95 | Oral leukoplakia (HP:0002745) | 2.01991649 |
96 | CNS demyelination (HP:0007305) | 2.00494457 |
97 | Rough bone trabeculation (HP:0100670) | 2.00435261 |
98 | Emotional lability (HP:0000712) | 1.97911325 |
99 | Aplasia/Hypoplasia of the lens (HP:0008063) | 1.97846000 |
100 | Degeneration of anterior horn cells (HP:0002398) | 1.97140205 |
101 | Abnormality of the anterior horn cell (HP:0006802) | 1.97140205 |
102 | Aplasia/hypoplasia of the uterus (HP:0008684) | 1.97107301 |
103 | Cleft eyelid (HP:0000625) | 1.95899703 |
104 | Impaired pain sensation (HP:0007328) | 1.95514702 |
105 | Abnormality of pain sensation (HP:0010832) | 1.95514702 |
106 | Generalized hypotonia (HP:0001290) | 1.94563934 |
107 | Neoplasm of the peripheral nervous system (HP:0100007) | 1.94067445 |
108 | Epileptiform EEG discharges (HP:0011182) | 1.93394922 |
109 | Sclerocornea (HP:0000647) | 1.92276850 |
110 | Congenital stationary night blindness (HP:0007642) | 1.91402282 |
111 | Oligomenorrhea (HP:0000876) | 1.90964846 |
112 | Pancreatic fibrosis (HP:0100732) | 1.90775315 |
113 | Progressive inability to walk (HP:0002505) | 1.90646311 |
114 | Increased hepatocellular lipid droplets (HP:0006565) | 1.87606043 |
115 | Decreased electroretinogram (ERG) amplitude (HP:0000654) | 1.87107564 |
116 | Severe muscular hypotonia (HP:0006829) | 1.86365587 |
117 | Retinal dysplasia (HP:0007973) | 1.85982847 |
118 | Neoplasm of the adrenal gland (HP:0100631) | 1.85746236 |
119 | Truncal ataxia (HP:0002078) | 1.85479954 |
120 | Hypoventilation (HP:0002791) | 1.84160149 |
121 | IgG deficiency (HP:0004315) | 1.82903374 |
122 | Inability to walk (HP:0002540) | 1.82878769 |
123 | Cerebral hypomyelination (HP:0006808) | 1.80817044 |
124 | Pendular nystagmus (HP:0012043) | 1.80242070 |
125 | Abnormality of the corticospinal tract (HP:0002492) | 1.78602715 |
126 | X-linked dominant inheritance (HP:0001423) | 1.77235899 |
127 | Unsteady gait (HP:0002317) | 1.76504866 |
128 | Sensory axonal neuropathy (HP:0003390) | 1.73733077 |
129 | Heterochromia iridis (HP:0001100) | 1.73176616 |
130 | Increased IgM level (HP:0003496) | 1.72663117 |
131 | Brushfield spots (HP:0001088) | 1.71759823 |
132 | Abnormal gallbladder physiology (HP:0012438) | 1.71339614 |
133 | Cholecystitis (HP:0001082) | 1.71339614 |
134 | Protruding tongue (HP:0010808) | 1.70729092 |
135 | Patellar aplasia (HP:0006443) | 1.70366869 |
136 | Cerebral palsy (HP:0100021) | 1.69929864 |
137 | Abnormal biliary tract physiology (HP:0012439) | 1.69561874 |
138 | Bile duct proliferation (HP:0001408) | 1.69561874 |
139 | EEG with generalized epileptiform discharges (HP:0011198) | 1.68908831 |
140 | Incomplete penetrance (HP:0003829) | 1.68754023 |
141 | Respiratory difficulties (HP:0002880) | 1.68545950 |
142 | Neuroblastic tumors (HP:0004376) | 1.66534999 |
143 | Peripheral primitive neuroectodermal neoplasm (HP:0030067) | 1.66534999 |
144 | Neuroblastoma (HP:0003006) | 1.66534999 |
145 | Primitive neuroectodermal tumor (HP:0030065) | 1.66534999 |
146 | Gliosis (HP:0002171) | 1.65596317 |
147 | Congenital, generalized hypertrichosis (HP:0004540) | 1.65167279 |
148 | Short tibia (HP:0005736) | 1.64730612 |
149 | Abnormal trabecular bone morphology (HP:0100671) | 1.63642171 |
150 | Tongue fasciculations (HP:0001308) | 1.63595281 |
151 | Optic nerve coloboma (HP:0000588) | 1.63249726 |
152 | Aplasia/Hypoplasia of the patella (HP:0006498) | 1.63188829 |
153 | Nephronophthisis (HP:0000090) | 1.61654978 |
154 | Death in infancy (HP:0001522) | 1.61128658 |
155 | Sparse eyelashes (HP:0000653) | 1.61025112 |
156 | Impaired vibration sensation in the lower limbs (HP:0002166) | 1.60734274 |
157 | Renal Fanconi syndrome (HP:0001994) | 1.60669150 |
158 | Abnormality of renal resorption (HP:0011038) | 1.60205312 |
159 | Aplasia/Hypoplasia of the tibia (HP:0005772) | 1.60079207 |
160 | Ankle clonus (HP:0011448) | 1.59678839 |
161 | Broad foot (HP:0001769) | 1.59233998 |
162 | Hypoplasia of the pons (HP:0012110) | 1.58424890 |
163 | Blindness (HP:0000618) | 1.58373817 |
164 | Scanning speech (HP:0002168) | 1.58023859 |
165 | Congenital nonbullous ichthyosiform erythroderma (HP:0007479) | 1.57832375 |
166 | Hypsarrhythmia (HP:0002521) | 1.57204270 |
167 | Generalized aminoaciduria (HP:0002909) | 1.56961263 |
168 | Autoamputation (HP:0001218) | 1.56533291 |
Rank | Gene Set | Z-score |
---|---|---|
1 | CASK | 5.95700944 |
2 | VRK2 | 5.37096952 |
3 | MAP3K12 | 4.01993157 |
4 | TESK2 | 3.99782693 |
5 | PRPF4B | 3.15780331 |
6 | MAP2K7 | 3.05364581 |
7 | BCKDK | 3.03413244 |
8 | NME2 | 2.92913279 |
9 | NTRK3 | 2.82265962 |
10 | AKT3 | 2.81726839 |
11 | TESK1 | 2.71877644 |
12 | SIK3 | 2.48005805 |
13 | TLK1 | 2.26737358 |
14 | PLK2 | 2.24580173 |
15 | MINK1 | 2.16367184 |
16 | TSSK6 | 2.11651150 |
17 | EPHA4 | 2.08962625 |
18 | CDK19 | 2.07698323 |
19 | ZAK | 2.04833579 |
20 | MAP3K4 | 1.97191819 |
21 | ARAF | 1.91057125 |
22 | TAOK1 | 1.84066210 |
23 | BMPR2 | 1.83499871 |
24 | KDR | 1.82227675 |
25 | TRIM28 | 1.79598805 |
26 | DAPK1 | 1.77647802 |
27 | MAP3K11 | 1.76507453 |
28 | STK16 | 1.70762998 |
29 | PRKCI | 1.63483358 |
30 | MAPK13 | 1.55822638 |
31 | SGK2 | 1.55620389 |
32 | BCR | 1.48714440 |
33 | NME1 | 1.48639307 |
34 | MAP4K2 | 1.44357130 |
35 | CSNK1G3 | 1.42555928 |
36 | GRK5 | 1.41100440 |
37 | SGK223 | 1.41066068 |
38 | SGK494 | 1.41066068 |
39 | CCNB1 | 1.37313008 |
40 | MARK1 | 1.36777976 |
41 | BRAF | 1.36115702 |
42 | MYLK | 1.30408892 |
43 | DAPK2 | 1.26893885 |
44 | NUAK1 | 1.26875620 |
45 | OXSR1 | 1.23738630 |
46 | NTRK2 | 1.22024846 |
47 | MKNK2 | 1.19256285 |
48 | CAMK1D | 1.17139759 |
49 | PRKCG | 1.16760398 |
50 | CSNK1G1 | 1.16383156 |
51 | MAP2K4 | 1.15617357 |
52 | ERBB3 | 1.14915537 |
53 | GRK7 | 1.14858256 |
54 | RIPK4 | 1.14465447 |
55 | PAK6 | 1.13106992 |
56 | MAPKAPK3 | 1.11424389 |
57 | INSRR | 1.08687190 |
58 | MKNK1 | 1.06770440 |
59 | LIMK1 | 1.06723690 |
60 | ADRBK2 | 1.06668510 |
61 | CSNK1G2 | 1.05953693 |
62 | TNIK | 1.05877768 |
63 | MUSK | 1.04325414 |
64 | YES1 | 1.04208924 |
65 | UHMK1 | 0.99708731 |
66 | BMPR1B | 0.97251797 |
67 | CSNK1A1L | 0.96937478 |
68 | PNCK | 0.96524495 |
69 | EPHA2 | 0.95117850 |
70 | MAP4K1 | 0.94943637 |
71 | KSR1 | 0.94375607 |
72 | SMG1 | 0.90719930 |
73 | PLK3 | 0.90250670 |
74 | CAMK2A | 0.89897216 |
75 | CDC7 | 0.83144327 |
76 | TXK | 0.83049561 |
77 | GRK1 | 0.82973864 |
78 | CDK5 | 0.81514297 |
79 | PINK1 | 0.80186441 |
80 | CAMK2B | 0.79982828 |
81 | CDK18 | 0.79336871 |
82 | BUB1 | 0.78321739 |
83 | PBK | 0.76858939 |
84 | ADRBK1 | 0.76154807 |
85 | PRKCE | 0.75469328 |
86 | SGK3 | 0.74628365 |
87 | EIF2AK1 | 0.73579471 |
88 | CDK8 | 0.72650524 |
89 | MAP3K9 | 0.70336884 |
90 | SRPK1 | 0.70279653 |
91 | CDK14 | 0.68105275 |
92 | PLK1 | 0.66272115 |
93 | NTRK1 | 0.66005668 |
94 | ATR | 0.65147680 |
95 | VRK1 | 0.64025347 |
96 | CDK15 | 0.63376693 |
97 | BRSK1 | 0.63185714 |
98 | TNK2 | 0.62390408 |
99 | RPS6KA5 | 0.62064146 |
100 | IRAK3 | 0.60678769 |
101 | PASK | 0.59856057 |
102 | MST4 | 0.59281555 |
103 | DAPK3 | 0.58625140 |
104 | PAK4 | 0.57618263 |
105 | PRKD2 | 0.57489913 |
106 | MAP2K6 | 0.56860893 |
107 | EIF2AK3 | 0.56755798 |
108 | NEK6 | 0.55694557 |
109 | RPS6KA2 | 0.55402111 |
110 | PIM2 | 0.54359350 |
111 | CDK11A | 0.54273885 |
112 | PTK2B | 0.54265790 |
113 | CAMKK1 | 0.53691875 |
114 | PAK1 | 0.52774666 |
115 | CAMKK2 | 0.50545970 |
116 | AURKB | 0.49387256 |
117 | DYRK1A | 0.48421327 |
118 | DYRK2 | 0.48029690 |
119 | GRK6 | 0.47630451 |
120 | IKBKB | 0.47220119 |
121 | ROCK2 | 0.46519933 |
122 | AURKA | 0.46198769 |
123 | FES | 0.44471895 |
124 | CAMK2D | 0.43174696 |
125 | CSNK2A1 | 0.42864336 |
126 | CAMK2G | 0.42440547 |
127 | MAPKAPK5 | 0.42014352 |
128 | ABL2 | 0.40949998 |
129 | CHEK2 | 0.40107408 |
130 | WNK4 | 0.39890397 |
131 | ILK | 0.39493185 |
132 | EIF2AK2 | 0.39261210 |
133 | RPS6KB1 | 0.39188859 |
134 | FGR | 0.37477575 |
135 | PRKACA | 0.36826734 |
136 | PLK4 | 0.36824762 |
137 | STK24 | 0.36033054 |
138 | MAP2K1 | 0.35449319 |
139 | TBK1 | 0.35038209 |
140 | CSNK2A2 | 0.33215633 |
141 | SGK1 | 0.33119130 |
142 | PHKG1 | 0.32531072 |
143 | PHKG2 | 0.32531072 |
144 | IRAK2 | 0.32357341 |
145 | RPS6KA4 | 0.31577721 |
146 | RPS6KC1 | 0.30484951 |
147 | RPS6KL1 | 0.30484951 |
148 | WNK3 | 0.29389687 |
149 | FER | 0.27170684 |
150 | CDK3 | 0.27083305 |
151 | STK38L | 0.25293001 |
152 | NEK1 | 0.25056800 |
153 | RPS6KA6 | 0.24115728 |
154 | CAMK1 | 0.23498704 |
155 | CSNK1A1 | 0.22327234 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 3.95028385 |
2 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 3.86988399 |
3 | Nicotine addiction_Homo sapiens_hsa05033 | 3.68810070 |
4 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 3.59023656 |
5 | Parkinsons disease_Homo sapiens_hsa05012 | 3.14045218 |
6 | Proteasome_Homo sapiens_hsa03050 | 2.58512765 |
7 | Alzheimers disease_Homo sapiens_hsa05010 | 2.50793316 |
8 | Olfactory transduction_Homo sapiens_hsa04740 | 2.47233789 |
9 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 2.46080880 |
10 | DNA replication_Homo sapiens_hsa03030 | 2.45185757 |
11 | Huntingtons disease_Homo sapiens_hsa05016 | 2.38276888 |
12 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 2.35597934 |
13 | GABAergic synapse_Homo sapiens_hsa04727 | 2.09614685 |
14 | Base excision repair_Homo sapiens_hsa03410 | 2.04694081 |
15 | Circadian entrainment_Homo sapiens_hsa04713 | 2.01430171 |
16 | Morphine addiction_Homo sapiens_hsa05032 | 2.00103472 |
17 | Long-term potentiation_Homo sapiens_hsa04720 | 1.96721197 |
18 | Amphetamine addiction_Homo sapiens_hsa05031 | 1.94578649 |
19 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.89557088 |
20 | Sulfur relay system_Homo sapiens_hsa04122 | 1.82869239 |
21 | Homologous recombination_Homo sapiens_hsa03440 | 1.80554226 |
22 | Taste transduction_Homo sapiens_hsa04742 | 1.79255409 |
23 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.77705538 |
24 | Mismatch repair_Homo sapiens_hsa03430 | 1.77274860 |
25 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.76211617 |
26 | Dopaminergic synapse_Homo sapiens_hsa04728 | 1.75987143 |
27 | Glutamatergic synapse_Homo sapiens_hsa04724 | 1.71419737 |
28 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 1.66625984 |
29 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 1.63610371 |
30 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 1.59534146 |
31 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 1.55624059 |
32 | Phototransduction_Homo sapiens_hsa04744 | 1.50252014 |
33 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 1.48962702 |
34 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.45098442 |
35 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.38848445 |
36 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 1.38466122 |
37 | Long-term depression_Homo sapiens_hsa04730 | 1.32990858 |
38 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.30353999 |
39 | Salivary secretion_Homo sapiens_hsa04970 | 1.25913122 |
40 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 1.25101162 |
41 | Calcium signaling pathway_Homo sapiens_hsa04020 | 1.23079067 |
42 | Cholinergic synapse_Homo sapiens_hsa04725 | 1.21788454 |
43 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 1.20844186 |
44 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.19932260 |
45 | Nucleotide excision repair_Homo sapiens_hsa03420 | 1.19547714 |
46 | Insulin secretion_Homo sapiens_hsa04911 | 1.16214960 |
47 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 1.14604617 |
48 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.09520514 |
49 | Renin secretion_Homo sapiens_hsa04924 | 1.07425592 |
50 | Glutathione metabolism_Homo sapiens_hsa00480 | 1.06509847 |
51 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.06173266 |
52 | Phagosome_Homo sapiens_hsa04145 | 1.04463248 |
53 | Cocaine addiction_Homo sapiens_hsa05030 | 1.03373209 |
54 | RNA polymerase_Homo sapiens_hsa03020 | 0.99523283 |
55 | RNA transport_Homo sapiens_hsa03013 | 0.99305349 |
56 | Gap junction_Homo sapiens_hsa04540 | 0.97205363 |
57 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.96490998 |
58 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.92547764 |
59 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.92327934 |
60 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.92150839 |
61 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.90923629 |
62 | Peroxisome_Homo sapiens_hsa04146 | 0.88609722 |
63 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.87307975 |
64 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.86320345 |
65 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.85667625 |
66 | Non-homologous end-joining_Homo sapiens_hsa03450 | 0.84116635 |
67 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.83850118 |
68 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 0.81739638 |
69 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.80433816 |
70 | Axon guidance_Homo sapiens_hsa04360 | 0.79624115 |
71 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.78306248 |
72 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.76488799 |
73 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.76222600 |
74 | Protein export_Homo sapiens_hsa03060 | 0.75746341 |
75 | Carbon metabolism_Homo sapiens_hsa01200 | 0.75108828 |
76 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.75074174 |
77 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.75072794 |
78 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.73229085 |
79 | Melanogenesis_Homo sapiens_hsa04916 | 0.71183485 |
80 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.70261359 |
81 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.68984777 |
82 | Alcoholism_Homo sapiens_hsa05034 | 0.68203142 |
83 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.65792743 |
84 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.64827942 |
85 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.64314064 |
86 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.63531066 |
87 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.63323545 |
88 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.61156152 |
89 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.60937392 |
90 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.60878062 |
91 | Allograft rejection_Homo sapiens_hsa05330 | 0.60685533 |
92 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.59992578 |
93 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.59622194 |
94 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.58968805 |
95 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.57190913 |
96 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.55709237 |
97 | Asthma_Homo sapiens_hsa05310 | 0.55139886 |
98 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.53652281 |
99 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.53064685 |
100 | Basal transcription factors_Homo sapiens_hsa03022 | 0.51112962 |
101 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.50046509 |
102 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.49578160 |
103 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.49156274 |
104 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.48864896 |
105 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.48570740 |
106 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.47338367 |
107 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.47019399 |
108 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.46364443 |
109 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.46225822 |
110 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.46219481 |
111 | Purine metabolism_Homo sapiens_hsa00230 | 0.43865017 |
112 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.43485059 |
113 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.42289838 |
114 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.38983227 |
115 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.38675039 |
116 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.37174491 |
117 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.35431532 |
118 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.34982494 |
119 | Glioma_Homo sapiens_hsa05214 | 0.34698238 |
120 | Wnt signaling pathway_Homo sapiens_hsa04310 | 0.34349999 |
121 | Melanoma_Homo sapiens_hsa05218 | 0.33334456 |
122 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.32818734 |
123 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 0.32796233 |
124 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.31063056 |
125 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.29605063 |
126 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.29226668 |
127 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.25487795 |
128 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.24538487 |
129 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.23955769 |
130 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.23313936 |
131 | Prion diseases_Homo sapiens_hsa05020 | 0.22736501 |
132 | Ribosome_Homo sapiens_hsa03010 | 0.22459811 |
133 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.22345036 |
134 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.21770158 |
135 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.21034119 |
136 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 0.20560473 |
137 | Spliceosome_Homo sapiens_hsa03040 | 0.20340275 |
138 | Metabolic pathways_Homo sapiens_hsa01100 | 0.19751930 |
139 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.18859212 |
140 | Hedgehog signaling pathway_Homo sapiens_hsa04340 | 0.17020269 |
141 | Galactose metabolism_Homo sapiens_hsa00052 | 0.15396459 |
142 | Lysosome_Homo sapiens_hsa04142 | 0.15355757 |
143 | Cell cycle_Homo sapiens_hsa04110 | 0.15024455 |
144 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.13622740 |
145 | Salmonella infection_Homo sapiens_hsa05132 | 0.12969345 |
146 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.12633433 |
147 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 0.12523380 |
148 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.12397737 |
149 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.11018850 |
150 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.09916882 |
151 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.09693473 |
152 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.09688418 |
153 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.08836621 |
154 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.08792169 |
155 | RNA degradation_Homo sapiens_hsa03018 | 0.08551807 |